Used in pharmaceutical research as a key intermediate in the synthesis of peroxisome proliferator-activated receptor (PPAR) modulators, particularly for developing antidiabetic agents. Its structure supports binding to nuclear receptors involved in glucose and lipid metabolism. Commonly employed in the development of thiazolidinedione-based drugs, where it contributes to improving insulin sensitivity in type 2 diabetes. Also explored for anti-inflammatory and antineoplastic properties due to its ability to influence cell differentiation and apoptosis. Suitable for use in structure-activity relationship (SAR) studies aimed at optimizing metabolic stability and receptor selectivity.